Asensus Surgical Statistics
Total Valuation
ASXC has a market cap or net worth of $92.55 million. The enterprise value is $88.54 million.
| Market Cap | 92.55M |
| Enterprise Value | 88.54M |
Important Dates
The next estimated earnings date is Thursday, August 8, 2024, after market close.
| Earnings Date | Aug 8, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
ASXC has 272.62 million shares outstanding. The number of shares has increased by 13.00% in one year.
| Shares Outstanding | 272.62M |
| Shares Change (YoY) | +13.00% |
| Shares Change (QoQ) | +1.80% |
| Owned by Insiders (%) | 2.06% |
| Owned by Institutions (%) | 17.42% |
| Float | 245.30M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 10.61 |
| Forward PS | 4.89 |
| PB Ratio | 7.11 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 10.15 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.00, with a Debt / Equity ratio of 0.42.
| Current Ratio | 1.00 |
| Quick Ratio | 0.53 |
| Debt / Equity | 0.42 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -202.90% and return on invested capital (ROIC) is -402.68%.
| Return on Equity (ROE) | -202.90% |
| Return on Assets (ROA) | -126.40% |
| Return on Capital (ROIC) | -402.68% |
| Revenue Per Employee | $41,742 |
| Profits Per Employee | -$376,612 |
| Employee Count | 209 |
| Asset Turnover | 0.14 |
| Inventory Turnover | 1.11 |
Taxes
In the past 12 months, ASXC has paid $269,000 in taxes.
| Income Tax | 269,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -44.02% in the last 52 weeks. The beta is 1.38, so ASXC's price volatility has been higher than the market average.
| Beta (5Y) | 1.38 |
| 52-Week Price Change | -44.02% |
| 50-Day Moving Average | 0.30 |
| 200-Day Moving Average | 0.28 |
| Relative Strength Index (RSI) | 66.56 |
| Average Volume (20 Days) | 2,053,730 |
Short Selling Information
The latest short interest is 11.32 million, so 4.15% of the outstanding shares have been sold short.
| Short Interest | 11.32M |
| Short Previous Month | 12.91M |
| Short % of Shares Out | 4.15% |
| Short % of Float | 4.61% |
| Short Ratio (days to cover) | 2.73 |
Income Statement
In the last 12 months, ASXC had revenue of $8.72 million and -$78.71 million in losses. Loss per share was -$0.30.
| Revenue | 8.72M |
| Gross Profit | -4.54M |
| Operating Income | -74.42M |
| Pretax Income | -78.44M |
| Net Income | -78.71M |
| EBITDA | -74.68M |
| EBIT | -78.44M |
| Loss Per Share | -$0.30 |
Balance Sheet
The company has $9.47 million in cash and $5.46 million in debt, giving a net cash position of $4.02 million or $0.01 per share.
| Cash & Cash Equivalents | 9.47M |
| Total Debt | 5.46M |
| Net Cash | 4.02M |
| Net Cash Per Share | $0.01 |
| Equity (Book Value) | 13.02M |
| Book Value Per Share | 0.05 |
| Working Capital | -40,000 |
Cash Flow
In the last 12 months, operating cash flow was -$60.39 million and capital expenditures -$497,000, giving a free cash flow of -$60.88 million.
| Operating Cash Flow | -60.39M |
| Capital Expenditures | -497,000 |
| Free Cash Flow | -60.88M |
| FCF Per Share | -$0.23 |
Margins
Gross margin is -52.04%, with operating and profit margins of -852.99% and -902.25%.
| Gross Margin | -52.04% |
| Operating Margin | -852.99% |
| Pretax Margin | -899.16% |
| Profit Margin | -902.25% |
| EBITDA Margin | -856.08% |
| EBIT Margin | -899.16% |
| FCF Margin | -697.89% |
Dividends & Yields
ASXC does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -13.00% |
| Shareholder Yield | -13.00% |
| Earnings Yield | -85.05% |
| FCF Yield | -65.78% |
Analyst Forecast
The average price target for ASXC is $0.35, which is 3.09% higher than the current price. The consensus rating is "Hold".
| Price Target | $0.35 |
| Price Target Difference | 3.09% |
| Analyst Consensus | Hold |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | 79.18% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on December 12, 2019. It was a reverse split with a ratio of 1:13.
| Last Split Date | Dec 12, 2019 |
| Split Type | Reverse |
| Split Ratio | 1:13 |
Scores
ASXC has an Altman Z-Score of -37.13 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -37.13 |
| Piotroski F-Score | 4 |